The $2.2 trillion stimulus package signed into law last week (aka the Coronavirus Aid, Relief, Economic Security Act, or CARES) has prompted an outcry from people upset at what appears to be generous provisions for Corporate America. Particular ire has been directed at executive compensation and share buybacks. Accordingly, the final legislation included language limiting dividends, buybacks and increases in executive compensation (although these can be waived on a case-by-case basis).
This article is only available to Macro Hive subscribers. Sign-up to receive world-class macro analysis with a daily curated newsletter, podcast, original content from award-winning researchers, cross market strategy, equity insights, trade ideas, crypto flow frameworks, academic paper summaries, explanation and analysis of market-moving events, community investor chat room, and more.